atorvastatin
Drug80 mg atorvastatin daily on two following days
NCT Number: NCT00678522
We wanted to test the hypothesis that acute treatment with atorvastatin changes renal sodium excretion, glomerular filtration rate, tubular function and vasoactive hormones in patients with type II diabetes, not in treatment with insulin.
Looking for future studies?
Notify Me40 year–70 year
All sexes
Interventional
Phase 4
Department of Medical Research, Holstebro Hospital, Holstebro, Denmark
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
80 mg atorvastatin daily on two following days
Time frame: 6 months
Time frame: 6 months
Regional Hospital Holstebro
Other
The Acute Effect of Atorvastatin on Renal Sodium Excretion, Glomerular Filtration Rate, Tubular Function and Vasoactive Hormones in Patients With Non-Insulin Dependent Type II Diabetes.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02218099
Chronic Disease, Chronic Kidney Disease (CKD)
Sofia, Bulgaria
View Trial DetailsNCT05943886
Body Weight, Diabetes Mellitus
Changchun, Jilin, China
View Trial DetailsNCT03802487
Diabetes Mellitus, Diabetes Mellitus, Type 2
Nottingham, United Kingdom
View Trial DetailsNCT03776227
Diabetes Mellitus, Diabetes Mellitus, Type 2
Miami, Florida, United States
View Trial Details